Today Oct 27, 2021
Event Image
Back to Events

Clinical Cases in Polycythemia Vera: When to Intervene With Jakafi® (ruxolitinib) | Focus on Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea

Wednesday Oct 20, 2021
Event Time 12:15 - 12:45 PM ET
Registration Closed
Event Faculty

Sara Tinsley, PhD, ARNP, AOCN

Nurse Practitioner
Moffitt Cancer Center
Tampa, FL

Learning Objectives:
*Identify and manage the clinical characteristics of advanced PV, including NCCN Guideline recommendations
*Discuss the pivotal RESPONSE trial of Jakafi® (ruxolitinib) in patients with PV who are resistant or intolerant to hydroxyurea, including primary outcomes, safety, and long-term data  
*Apply clinical concepts to a case study of a real-world patient with clinical characteristics of advanced PV 

Event Sponsors